ID

31773

Descripción

Safety and Efficacy Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing-Remitting Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT00390221

Link

https://clinicaltrials.gov/show/NCT00390221

Palabras clave

Versiones (1)
  1. 27/9/18 27/9/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

27 de septiembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Relapsing-Remitting Multiple Sclerosis NCT00390221

Inglés

Eligibility Relapsing-Remitting Multiple Sclerosis NCT00390221

1 formularios  
Criteria
Descripción

Criteria

multiple sclerosis (ms) subjects who have a confirmed diagnosis of relapsing-remitting ms according to mcdonald criteria #1-4 and a baseline expanded disability status scale (edss) between 0.0 and 5.0, inclusive, who meet either of the following 2 criteria
Descripción

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | EDSS

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0026769
UMLS CUI [2]
C0751967
UMLS CUI [3]
C0451246
have experienced at least 1 relapse within the 12 months prior to randomization, with a cranial magnetic resonance imaging (mri) demonstrating lesion(s) consistent with ms , or
Descripción

Relapse Quantity | Lesion Consistent with Multiple Sclerosis | MRI Cranium

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0035020
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C0221198
UMLS CUI [2,2]
C0332290
UMLS CUI [2,3]
C0026769
UMLS CUI [3,1]
C0024485
UMLS CUI [3,2]
C0037303
show evidence of gadolinium-enhancing lesions of the brain on an mri performed within the 6 weeks prior to randomization.
Descripción

Lesion of brain Nuclear magnetic resonance imaging gadolinium-enhanced

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0221505
UMLS CUI [1,2]
C0855566
key exclusion criteria:
Descripción

Exclusion Criteria Main

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1542147
diagnosis of primary progressive, secondary progressive, or progressive relapsing ms
Descripción

Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Progressive Relapsing

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0751964
UMLS CUI [2]
C0751965
UMLS CUI [3]
C0393666
history of malignancy
Descripción

Malignant Neoplasms

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
history of severe allergic or anaphylactic reactions or known drug hypersensitivity
Descripción

Severe allergic reaction | Anaphylaxis Severe | Drug Allergy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2220378
UMLS CUI [2,1]
C0002792
UMLS CUI [2,2]
C0205082
UMLS CUI [3]
C0013182
history of abnormal laboratory results
Descripción

Laboratory test result abnormal

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0438215
history of human immunodeficiency virus (hiv) or other immunodeficient conditions
Descripción

HIV Infection | Immunodeficiency

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019693
UMLS CUI [2]
C0021051
history of drug or alcohol abuse within the 2 years prior to randomization
Descripción

Substance Use Disorders

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038586
an ms relapse that has occurred within the 50 days prior to randomization and/or the subject has not stabilized from a previous relapse prior to randomization
Descripción

Multiple sclerosis relapse | Relapse Previous Without Stabilization

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0856120
UMLS CUI [2,1]
C0035020
UMLS CUI [2,2]
C0205156
UMLS CUI [2,3]
C0332288
UMLS CUI [2,4]
C1293130
positive screening for active infection with hepatitis b virus or hepatitis c virus
Descripción

Hepatitis B positive | Hepatitis C positive

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0856706
UMLS CUI [2]
C1112419
varicella or herpes zoster virus infection or any severe viral infection within 6 weeks before screening
Descripción

Varicella Zoster Virus Infection | Herpes zoster infection | Viral infection severe

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0586989
UMLS CUI [2]
C0019360
UMLS CUI [3,1]
C0042769
UMLS CUI [3,2]
C0205082
exposure to varicella zoster virus within 21 days before screening.
Descripción

Exposure to Varicella zoster virus

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C0042338
abnormal blood tests at screening; hemoglobin ≤9.0 g/dl, platelets ≤100 × 109/l, lymphocytes ≤1.0 × 109/l, neutrophils ≤1.5 × 109/l, alanine aminotransferase/serum glutamate pyruvate transaminase (alt/sgpt), aspartate aminotransferase/serum glutamic oxaloacetic transaminase (ast/sgot), or gamma-glutamyl-transferase >2 times the upper limit of normal (uln) and serum creatinine >uln.
Descripción

Abnormal blood test | Hemoglobin measurement | Platelet Count measurement | Lymphocyte Count measurement | Neutrophil count | Alanine aminotransferase increased | Aspartate aminotransferase increased | Gamma-glutamyl transferase raised | Serum creatinine raised

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0854146
UMLS CUI [2]
C0518015
UMLS CUI [3]
C0032181
UMLS CUI [4]
C0200635
UMLS CUI [5]
C0200633
UMLS CUI [6]
C0151905
UMLS CUI [7]
C0151904
UMLS CUI [8]
C0151662
UMLS CUI [9]
C0700225
note: other protocol defined inclusion/exclusion criteria may apply.
Descripción

Eligibility Criteria Study Protocol

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Volver a la parte superior de la página

Similar models

Eligibility Relapsing-Remitting Multiple Sclerosis NCT00390221

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | EDSS
Item
multiple sclerosis (ms) subjects who have a confirmed diagnosis of relapsing-remitting ms according to mcdonald criteria #1-4 and a baseline expanded disability status scale (edss) between 0.0 and 5.0, inclusive, who meet either of the following 2 criteria
boolean
C0026769 (UMLS CUI [1])
C0751967 (UMLS CUI [2])
C0451246 (UMLS CUI [3])
Relapse Quantity | Lesion Consistent with Multiple Sclerosis | MRI Cranium
Item
have experienced at least 1 relapse within the 12 months prior to randomization, with a cranial magnetic resonance imaging (mri) demonstrating lesion(s) consistent with ms , or
boolean
C0035020 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0221198 (UMLS CUI [2,1])
C0332290 (UMLS CUI [2,2])
C0026769 (UMLS CUI [2,3])
C0024485 (UMLS CUI [3,1])
C0037303 (UMLS CUI [3,2])
Lesion of brain Nuclear magnetic resonance imaging gadolinium-enhanced
Item
show evidence of gadolinium-enhancing lesions of the brain on an mri performed within the 6 weeks prior to randomization.
boolean
C0221505 (UMLS CUI [1,1])
C0855566 (UMLS CUI [1,2])
Exclusion Criteria Main
Item
key exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Progressive Relapsing
Item
diagnosis of primary progressive, secondary progressive, or progressive relapsing ms
boolean
C0751964 (UMLS CUI [1])
C0751965 (UMLS CUI [2])
C0393666 (UMLS CUI [3])
Malignant Neoplasms
Item
history of malignancy
boolean
C0006826 (UMLS CUI [1])
Severe allergic reaction | Anaphylaxis Severe | Drug Allergy
Item
history of severe allergic or anaphylactic reactions or known drug hypersensitivity
boolean
C2220378 (UMLS CUI [1])
C0002792 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0013182 (UMLS CUI [3])
Laboratory test result abnormal
Item
history of abnormal laboratory results
boolean
C0438215 (UMLS CUI [1])
HIV Infection | Immunodeficiency
Item
history of human immunodeficiency virus (hiv) or other immunodeficient conditions
boolean
C0019693 (UMLS CUI [1])
C0021051 (UMLS CUI [2])
Substance Use Disorders
Item
history of drug or alcohol abuse within the 2 years prior to randomization
boolean
C0038586 (UMLS CUI [1])
Multiple sclerosis relapse | Relapse Previous Without Stabilization
Item
an ms relapse that has occurred within the 50 days prior to randomization and/or the subject has not stabilized from a previous relapse prior to randomization
boolean
C0856120 (UMLS CUI [1])
C0035020 (UMLS CUI [2,1])
C0205156 (UMLS CUI [2,2])
C0332288 (UMLS CUI [2,3])
C1293130 (UMLS CUI [2,4])
Hepatitis B positive | Hepatitis C positive
Item
positive screening for active infection with hepatitis b virus or hepatitis c virus
boolean
C0856706 (UMLS CUI [1])
C1112419 (UMLS CUI [2])
Varicella Zoster Virus Infection | Herpes zoster infection | Viral infection severe
Item
varicella or herpes zoster virus infection or any severe viral infection within 6 weeks before screening
boolean
C0586989 (UMLS CUI [1])
C0019360 (UMLS CUI [2])
C0042769 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
Exposure to Varicella zoster virus
Item
exposure to varicella zoster virus within 21 days before screening.
boolean
C0332157 (UMLS CUI [1,1])
C0042338 (UMLS CUI [1,2])
Abnormal blood test | Hemoglobin measurement | Platelet Count measurement | Lymphocyte Count measurement | Neutrophil count | Alanine aminotransferase increased | Aspartate aminotransferase increased | Gamma-glutamyl transferase raised | Serum creatinine raised
Item
abnormal blood tests at screening; hemoglobin ≤9.0 g/dl, platelets ≤100 × 109/l, lymphocytes ≤1.0 × 109/l, neutrophils ≤1.5 × 109/l, alanine aminotransferase/serum glutamate pyruvate transaminase (alt/sgpt), aspartate aminotransferase/serum glutamic oxaloacetic transaminase (ast/sgot), or gamma-glutamyl-transferase >2 times the upper limit of normal (uln) and serum creatinine >uln.
boolean
C0854146 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0200635 (UMLS CUI [4])
C0200633 (UMLS CUI [5])
C0151905 (UMLS CUI [6])
C0151904 (UMLS CUI [7])
C0151662 (UMLS CUI [8])
C0700225 (UMLS CUI [9])
Eligibility Criteria Study Protocol
Item
note: other protocol defined inclusion/exclusion criteria may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial